ImmunoGen (IMGN) to Make Several Poster Presentations as AACR-NCI-EORTC Conference

ImmunoGen, Inc. (NASDAQ: IMGN) announced today that several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.

ImmunoGen posters on Nov. 16, 12:30 - 2:30 PM:

• "The effect of linker on target cell catabolism and PK/PD of trastuzumab-maytansinoid conjugates" (abstract #A149) at Poster session A; Drug Metabolism, Transport, and Biodistribution.
  
  
  ImmunoGen posters on Nov. 17, 12:30 - 2:30 PM:
  • "Clinical experience of IMGN901 (BB-10901, huN901-DM1) in patients with Merkel cell carcinoma (MCC)" (abstract #B237) at Poster session B; Therapeutic Agents: Biological 1.
    
    
  • "Potent antigen-specific anti-tumor activity observed with antibody-drug conjugates (ADCs) made using a new class of DNA-crosslinking agents" (abstract #B126) at Poster session B; Monoclonal Antibodies.
    
    
  • "Designing potent antibody-drug conjugates: The impact of lysosomal processing efficiency and conjugate linker selection on anticancer activity" (abstract #B120) at Poster session B; Monoclonal Antibodies.
  
  

  Related Categories

  Corporate News
  
  

  Stocks Mentioned

  IMGN 8.35

  +0.31 +3.86%
  Volume: 562,242
  Track IMGN

  
  

  Add Your Comment

  Name

  Subject

  Body

  Verification can't see the text?
  click here to refresh the image.
  what's this?
  
  
  

  Sign up for StreetInsider Free!

  Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!